SEC 13F Intelligence

Bristol John W & Co Inc /Ny/ / JNJ

Bristol John W & Co Inc /Ny/’s Johnson & Johnson Position

Does Bristol John W & Co Inc /Ny/ own Johnson & Johnson (JNJ)? Yes351.9K shares worth $86M (+1.42% of its 13F portfolio) as of Q1 2026, down from 473.2K shares the prior filed quarter.

Position Value
$86M
Q1 2026
Shares
351.9K
% of Portfolio
+1.42%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $70MQ4 ’18Q1 ’19: $76MQ2 ’19: $74MQ3 ’19: $76MQ4 ’19: $96MQ4 ’19Q1 ’20: $86MQ2 ’20: $91MQ3 ’20: $97MQ4 ’20: $102MQ4 ’20Q1 ’21: $106MQ2 ’21: $106MQ3 ’21: $102MQ4 ’21: $107MQ4 ’21Q1 ’22: $108MQ2 ’22: $105MQ3 ’22: $97MQ4 ’22: $106MQ4 ’22Q1 ’23: $83MQ2 ’23: $96MQ3 ’23: $90MQ4 ’23: $85MQ4 ’23Q1 ’24: $84MQ2 ’24: $241MQ3 ’24: $85MQ4 ’24: $73MQ4 ’24Q1 ’25: $82MQ2 ’25: $76MQ3 ’25: $90MQ4 ’25: $98MQ4 ’25Q1 ’26: $86Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026351.9K$86M+1.42%
Q4 2025473.2K$98M+1.51%
Q3 2025485.5K$90M+1.42%
Q2 2025496.9K$76M+1.23%
Q1 2025496.8K$82M+1.41%
Q4 2024507.0K$73M+1.20%
Q3 2024522.5K$85M+1.35%
Q2 20241.65M$241M+3.91%
Q1 2024532.9K$84M+1.44%
Q4 2023539.7K$85M+1.56%
Q3 2023575.5K$90M+1.77%
Q2 2023581.8K$96M+1.82%
Q1 2023533.5K$83M+1.70%
Q4 2022597.9K$106M+2.51%
Q3 2022593.5K$97M+2.42%
Q2 2022591.9K$105M+2.57%
Q1 2022611.6K$108M+2.15%
Q4 2021625.2K$107M+1.85%
Q3 2021632.8K$102M+1.91%
Q2 2021642.6K$106M+1.94%
Q1 2021647.9K$106M+2.18%
Q4 2020649.5K$102M+2.11%
Q3 2020652.9K$97M+2.20%
Q2 2020643.6K$91M+2.25%
Q1 2020654.5K$86M+2.67%
Q4 2019657.8K$96M+2.32%
Q3 2019545.4K$76M+1.96%
Q2 2019533.0K$74M+1.96%
Q1 2019540.9K$76M+2.07%
Q4 2018543.8K$70M+2.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bristol John W & Co Inc /Ny/’s full portfolio or all institutional holders of JNJ.